|Exchange:||NASDAQ national market|
|Shire PLC is a biopharmaceutical company that focuses on meeting the needs of the specialist physician. The Company develops and provides healthcare in the areas of Behavioral Health and Gastro Intestinal conditions; Rare Genetic Diseases; and Regenerative Medicine. The Company operates in three distinct business units; Specialty Pharmaceuticals, Human Genetic Therapies and Regenerative Medicine. Specialty Pharmaceuticals focus on small-molecule medications within the therapeutic areas of Behavioral Health and Gastro Intestinal disease, among others. Human Genetic Therapies is solely focused on researching, developing and marketing novel products and services that profoundly enhance the quality of life of patients suffering from rare genetic diseases. Regenerative Medicine provides regenerative medicine solutions for people with lifealtering conditions. The company operates in Ireland, United Kingdom, North America and Rest of World.|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.